Inspecs GroupINPEF 52 Market Cap is $139.4 Mil as of Jun. 26, 2026. GuruFocus rates INPEF with a GF Score™ of 52/100 and a GF Value™ of $0.65. The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Inspecs Group ranks better than 52.19% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Inspecs Group's share price for the quarter that ended in Dec. 2025 was $0. Inspecs Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 101.7 Mil. Therefore, Inspecs Group's market cap for the quarter that ended in Dec. 2025 was $0.0 Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Inspecs Group's Enterprise Value for Today is $197.1 Mil.
Inspecs Group (OTCPK:INPEF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Inspecs Group Market Cap Related Terms
Inspecs Group Market Cap Historical Data
* Premium members only.
The historical data trend for Inspecs Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Inspecs Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspecs Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Inspecs Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Inspecs Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspecs Group (INPEF) has a Market Cap of $139.4 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Inspecs Group and its competitors. According to the industry distribution chart, Inspecs Group ranks #414 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 47.8%.
Is Inspecs Group's Market Cap too high?
Inspecs Group's current Market Cap is $139.4 Mil. The Medical Devices & Instruments industry median Market Cap is 121.29. Inspecs Group's value of $139.4 Mil is 14.9% above this industry median. Based on the distribution chart, Inspecs Group ranks #414 out of 866 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Inspecs Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Inspecs Group ranks #414 out of 866 companies for Market Cap. This puts Inspecs Group in the upper half of its industry. The industry median Market Cap is 121.29. Inspecs Group's value of $139.4 Mil is 14.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspecs Group's current Market Cap of $139.4 Mil is 14.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Inspecs Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspecs Group's current Market Cap is $139.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Inspecs Group (INPEF) has a current Market Cap of $139.4 Mil. The stock's GF Value™ is $0.65, compared to a current price of $1.08 — trading 66.2% above its estimated fair value. The current Market Cap is $139.4 Mil and 14.9% above the Medical Devices & Instruments industry median of 121.29. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Inspecs Group (INPEF), the current Market Cap is $139.4 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspecs Group (INPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued.
The current stock price of $1.08 is trading 66.2% above its estimated GF Value™ of $0.65.
Key valuation signals for INPEF:
Market Cap: $139.4 Mil
GF Value™: $0.65 vs. price of $1.08 (66.2% above fair value)
Industry Position: 14.9% above the Medical Devices & Instruments median (#414 of 866)
No single metric tells the full story. See the INPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score
Get the complete analysis for INPEF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INPEF has been successfully added to your 
